FDA Cleared Exoskeleton for Home Use
The Eve device allows individuals with spinal cord injuries to stand and walk independently.
Updated on Oct. 10, 2026 in Stroke
Live Poll
Do you believe new robotic technologies will significantly improve independence for people with spinal injuries?
The FDA has granted clearance for the Eve self-balancing exoskeleton to be used in home settings. Wandercraft has officially launched sales of the device across the United States.
Why it matters
This technology aims to improve quality of life by enabling individuals with spinal cord injuries to perform daily movements without the need for crutches or walkers.
The Eve exoskeleton uses 12 motors and onboard sensors to assist movement, with 69 percent of participants in a 16-pair study reaching target walking speeds. Users operate the device for sitting, standing, and turning via an adapted joystick.
The players
Food and Drug Administration
The federal agency is responsible for protecting public health by ensuring the safety and efficacy of medical devices and human drugs.
Wandercraft
The technology company specializes in the development of self-balancing exoskeletons designed to assist individuals with mobility impairments.
The details
The device enables independent mobility by maintaining balance without external support like walkers. It is designed to assist users with spinal cord injuries in navigating their living spaces and performing everyday tasks.
Timeline
October 10, 2026: FDA clearance and launch of U.S. sales.
The Big Picture
The clearance of the Eve exoskeleton marks a shift in the availability of advanced assistive technologies within the CMS Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) benefit category. This move signals a broader transition toward integrating robotic mobility solutions into standard home care coverage.
Eligible patients may now pursue coverage for the device through Medicare, veterans' healthcare, or workers' compensation insurance. This provides a new pathway for home-based mobility support for those managing spinal cord injuries.
The takeaway
This technology represents a significant advancement in personal mobility tools for individuals with limited lower-limb function. Interested patients should consult with their healthcare providers to determine if the device meets their specific medical needs.
Further reading
Learn more about advancements in mobility support on the Stroke page.
Source note: This article includes information reported by The Portugal News.
Live Poll
Do you believe new robotic technologies will significantly improve independence for people with spinal injuries?
